Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rodolfo Dorado"'
Publikováno v:
Neuroscience Insights, Vol 18 (2023)
The term mild cognitive impairment (MCI) defines an intermediate state between normal aging and dementia. Vascular cognitive impairment refers to a decline in cognitive function that is caused by or associated with vascular disease and comprises all
Externí odkaz:
https://doaj.org/article/3c98572b5ceb4f25952604fb90789480
Publikováno v:
Toxicon. 123:S46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd449b41937944458a2b2b11c117c074
https://doi.org/10.1016/j.toxicon.2016.11.131
https://doi.org/10.1016/j.toxicon.2016.11.131
Publikováno v:
Revista de Neurología. 63:140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5a1ac37349e769223bc61502f348838
https://doi.org/10.33588/rn.6303.2016039
https://doi.org/10.33588/rn.6303.2016039
Publikováno v:
Headache. 49(9)
Objective.— To evaluate the effect of different migraine prophylaxis medications on subject responsiveness to almotriptan. Background.— There is evidence supporting an increase of responsiveness of symptomatic medications for migraine attacks by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b52cc915b8f830f604ff7375c1a71e2
https://pubmed.ncbi.nlm.nih.gov/19788470
https://pubmed.ncbi.nlm.nih.gov/19788470
Autor:
Roger K, Cady, Ninan, Mathew, Hans-Christoph, Diener, Peter, Hu, Magali, Haas, Gerald P, Novak, Rodolfo, Dorado
Publikováno v:
Headache. 49(2)
Objective.— This study explored the dose-response relationship of carisbamate administered at doses of 100 mg per day, 300 mg per day, or 600 mg per day, in the prevention of migraine. Background.— Carisbamate ([S]-2-O-carbamoyl-1-o-chlorophenyl-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94406684536974e171507d123b926a9c
https://pubmed.ncbi.nlm.nih.gov/19222595
https://pubmed.ncbi.nlm.nih.gov/19222595
Autor:
Rodolfo Dorado, Pedro Emilio Bermejo
Publikováno v:
Clinical neuropharmacology. 32(2)
Introduction Topiramate is a sulfamate-substituted monosaccharide that has proven efficacy in reducing migraine attacks frequency and severity and has similar mechanisms of action and side effects profile to zonisamide. Although there are some studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94f633e1841ecbf6170e404dbc41f341
https://pubmed.ncbi.nlm.nih.gov/18978487
https://pubmed.ncbi.nlm.nih.gov/18978487
Publikováno v:
Revista de Neurología. 61:47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a661c4eda49f6ff64466f053a36f8fbb
https://doi.org/10.33588/rn.6101.2015151
https://doi.org/10.33588/rn.6101.2015151